MKI67 and breast carcinoma: Concerning breast cancer, for instance, the evaluation of the proliferation index Ki-67 by immunohistochemical assay is one of the analyses performed to distinguish between luminal A (Ki-67 score < 20%) and luminal B subtypes (Ki-67 score ≥ 20%) [25].